180 related articles for article (PubMed ID: 12631072)
1. Rapamycin is an effective inhibitor of human renal cancer metastasis.
Luan FL; Ding R; Sharma VK; Chon WJ; Lagman M; Suthanthiran M
Kidney Int; 2003 Mar; 63(3):917-26. PubMed ID: 12631072
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.
Luan FL; Hojo M; Maluccio M; Yamaji K; Suthanthiran M
Transplantation; 2002 May; 73(10):1565-72. PubMed ID: 12042641
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression.
Maluccio M; Sharma V; Lagman M; Vyas S; Yang H; Li B; Suthanthiran M
Transplantation; 2003 Aug; 76(3):597-602. PubMed ID: 12923450
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer.
Boffa DJ; Luan F; Thomas D; Yang H; Sharma VK; Lagman M; Suthanthiran M
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):293-300. PubMed ID: 14734482
[TBL] [Abstract][Full Text] [Related]
5. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
Murphy GJ; Bicknell GR; Nicholson ML
Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Koehl GE; Andrassy J; Guba M; Richter S; Kroemer A; Scherer MN; Steinbauer M; Graeb C; Schlitt HJ; Jauch KW; Geissler EK
Transplantation; 2004 May; 77(9):1319-26. PubMed ID: 15167584
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
10. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth.
Gong Y; Lu J; Ding X; Yu Y
J Periodontal Res; 2014 Aug; 49(4):448-57. PubMed ID: 23947915
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
Huynh H; Chow PK; Palanisamy N; Salto-Tellez M; Goh BC; Lee CK; Somani A; Lee HS; Kalpana R; Yu K; Tan PH; Wu J; Soong R; Lee MH; Hor H; Soo KC; Toh HC; Tan P
J Hepatol; 2008 Jul; 49(1):52-60. PubMed ID: 18490075
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
13. Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer.
Stephan S; Datta K; Wang E; Li J; Brekken RA; Parangi S; Thorpe PE; Mukhopadhyay D
Clin Cancer Res; 2004 Oct; 10(20):6993-7000. PubMed ID: 15501979
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas.
Sebestyén A; Márk Á; Hajdu M; Nagy N; Molnár A; Végső G; Barna G; Kopper L
Cytokine; 2015 Jun; 73(2):219-24. PubMed ID: 25794661
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
Martin-Martin N; Slattery C; McMorrow T; Ryan MP
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1281-92. PubMed ID: 21880834
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Tan CJ; Qiu SJ; Yu Y; Huang XW; Tang ZY
J Cancer Res Clin Oncol; 2009 May; 135(5):715-22. PubMed ID: 19002496
[TBL] [Abstract][Full Text] [Related]
19. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
20. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
